End-stage myoglobinuric renal failure due to lovastatin therapy in preexisting chronic renal insufficiency: A case report;TERMINALES MYOGLOBINURISCHES NIERENVERSAGEN UNTER LOVASTATINTHERAPIE BEI PRAEXISTENTER CHRONISCHER NIERENFUNKTIONSSTORUNG

Wiener Klinische Wochenschrift

Volumn 108, Issue 11, 1996, Pages 334-337

  Biesenbach, G ^a,b   Janko, O ^a   Stuby, Ulrike ^a   Zazgornik, J ^a  

^a 2 Med Abt Allgemeinen Krankhs S   (Austria)

^b 2 Med Abt Allgemeinen Krankhs   (Austria)

Author keywords

HMG CoA reductase inhibitor; myoglobinuric renal failure

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; MEVINOLIN; PREDNISOLONE;

AGED; ARTICLE; CASE REPORT; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; RHABDOMYOLYSIS;

AGED; ANTICHOLESTEREMIC AGENTS; HUMANS; HYPERCHOLESTEROLEMIA; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; LOVASTATIN; MALE; MYOGLOBINURIA; NEPHROTIC SYNDROME; RENAL DIALYSIS;

EID: 0029948211     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Andrade SE et al (1995) Discontinuation of antihyperlipidemic drugs - do rates reported in clinical trials reflect rates in primary care settings? N Engl J Med 332: 1132-1136
2. Biesenbach G, Kaiser W, Kramar R, Herbinger W, Zazgornik J (1986) Dialysepflichtiges akutes Nierenversagen bei atraumatischer Rhabdomyolyse. In: Aktuelle Intensivmedizin 3. Schattauer, Stuttgart New York, S 363-371
3. Biesenbach G, Zazgornik J (1994) Lovastatin in the treatment of hypercholesterolemia in nephrotic syndrome due to diabetic nephropathy stage IV-V. Clin Nephrology 37: 274-279
4. Bock KD, Kreuzfelder E (1981) Rhabdomyolosis with acute renal failure due to bezafibrate. Klin Wochenschr 59: 413-416
5. Briner V, Colombi A, Brunner W, Truninger B (1986) Die akute Rhabdomyolyse. Schweiz Med Wochenschr 116: 198-208
6. Chan PCK, Robinson JD, Yeung WC, Cheng IKP, Yeung HWD, Tsang MTS (1992) Lovastatin in glomerulonephritis patients with hyperlipidaemia and heavy proteinuria. Nephrol Dial Transplant 7: 93-99
7. Corpier CL, Jones PH, Suki WN et al (1988) Rhabdomyolysis and renal injury with lovastatin usw. JAMA 260: 239-241
8. Greil R, Gattringer C, Abbrederis K (1985) Rhabdomyolyse als Spätkomplikation einer Anästhesie - ein Fall maligner Hyperthermie? Wien Klin Wochenschr 97: 813-819
9. Golper TA, Illingworth R, Morris CD, Bennett WM (1989) Lovastatin in the treatment of multifactorial hyperlipidemia associated with proteinuria. Am J Kidney Dis 13: 312-320
10. Harris KPG, Purkerson ML, Yates J, Klahr S (1990) Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome. Am J Kidney Dis 15: 16-23
11. Haubenstock A, Schmidt P, Zazgomik J, Balcke P. Kopsa H. Sertl K (1984) Bezafibrat-induzierte Rhabdomyolyse bei einem Patienten mit eingeschränkter Nierenfunktion. Dtsch Med Wochenschr 109: 157-158
12. Kasiske BL, Velosa JA, Haistenson CE, La Belle P, Langendörfer A, Keane WF (1990) The effects of lovastatin in hyperlipidemic patients with the nephrotic syndrome. Am J Kidney Dis 15: 8-15
13. Moorhead JF, Chan MK, El-Nahas M, Varghese Z (1982) Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet ii: 1309-1311
14. Tobert JA (1988) Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation. N Engl J Med 318: 48 (letter)
15. Traindl O et al (1992) Treatment of hyperlipidemic kidney graft recipients with lovastatin: effect on LDL-cholesterol and Lp(a). Nephron 62: 394-398
16. Wanner C, Bartens W (1994) Lipoproiein(a) in renal patients: is it a key factor in the high cardiovascular mortality? Nephrol Dial Transplant 9: 1066-1068